AcquisitionOther
MUSTANG BIO, INC. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
MUSTANG BIO, INC. -> target · $6 million
Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, commented, “We are very pleased to have closed this strategic transaction with uBriGene.
Open source record (SEC) ↗